Global Nutraceutical Goes Paperless in Corporate Validation; Selects Cloud-based ValGenesis VLMS

Since 1980, this global giant has been on a mission to change people’s lives through high-quality, science-backed nutrition supplements, weight management, sports nutrition, and personal care products.

SAN FRANCISCO, Dec. 5, 2018 /PRNewswire/ -- ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that a tier 1 global nutraceutical manufacturer has chosen ValGenesis’s cloud-based, 100% paperless Validation Lifecycle Management System to manage its global computer system validation (CSV) lifecycle process.

Since 1980, this global giant has been on a mission to change people’s lives through high-quality, science-backed nutrition supplements, weight management, sports nutrition, and personal care products. Operating in more than 90 countries with over 8,000 employees and a network of approximately 3.2 million independent distributors, the company attempts to provide solutions to worldwide problems of poor nutrition and obesity, an aging population, and skyrocketing public healthcare costs. Through corporate social responsibility efforts, it supports programs to help bring proper nutrition to children in need across the globe.

The company has previously faced inconsistency and inefficiencies with its paper-based approach to validation, with skilled personnel spending significant amounts of time on non-value-added activities. Additionally, they have seen a significant increase in their efforts to create and maintain traceability matrices during the computer system validation process. Recognizing that this traditional, paper-based method is both costly and inefficient, the company performed a thorough evaluation of options and selected ValGenesis’s VLMS—an electronic, paperless, cloud-based SaaS solution—to manage its computer system’s validation lifecycle across the organization. The company saw that the ValGenesis VLMS offered a state-of-the-art solution that complies with their current validation process while providing significant efficiency gains that greatly reduced validation cycle time, increased the standard of data integrity, improved regulatory compliance, and provided a holistic view of real-time validation status of their GxP systems and processes across the organization.

“This is another big win for ValGenesis, in that a global nutraceutical company has chosen our cloud-based software platform to manage validation requirements across their organization,” says Narayan Raj, Vice President of ValGenesis Inc. “We are very pleased to offer our Validation Lifecycle Management system to such an esteemed organization that must meet stringent validation requirements in the nutraceutical industry. This is testament to the fact that ValGenesis is a leader offering the best validation solutions in the market today. Life science companies are realizing that our cloud-based solution can help them get their innovative products and solutions to market more quickly.”

About ValGenesis

ValGenesis, Inc. is the creator of an innovative software platform that serves as the foundation for managing compliance-based validation activities in Life Science companies. ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. As the first fully paperless solution for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005. The solution is also fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements.

For more information, visit www.valgenesis.com

Further information:

Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026, 206020@email4pr.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/global-nutraceutical-goes-paperless-in-corporate-validation-selects-cloud-based-valgenesis-vlms-300760128.html

SOURCE ValGenesis Inc.

MORE ON THIS TOPIC